Programmed Cell Death in Cancer Progression and Therapy - Brossura
Libro 39 di 544: Advances in Experimental Medicine and Biology
Sinossi
Programmed cell death (PCD) plays pivotal roles in tumor progression, cancer therapeutics and resistance of tumor cells to therapy. This book examines the mechanisms involved in mediating and regulating PCD in cancer. It also provides a detailed indication of the utility of PCD in cancer therapy. The book features chapters on the current and future of RNA interference in therapeutics and Pathways involved in Stem Cell Survival and Death.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Review
From the reviews:
"Programmed cell death (PCD) is an intriguing term that was introduced by Richard Lockshin nearly 45 years ago. ... this book is about PCD with intense focus on apoptosis and the exploitation of PCD for treating cancer. ... All chapters are well edited and thoroughly referenced. The nicety of the book is the use of numerous color figures. In my opinion, both scientists and clinicians, experienced or beginning, will profit from a thoughtful reading of Programmed Cell Death in Cancer Progression and Therapy." (A. A. Philchenkov, Biochemistry (Moscow), Vol. 74 (4), 2009)
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
